Macquarie Group LTD Harvard Bioscience Inc Transaction History

Macquarie Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $5,736 - $9,070	-2,071 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$3.03 - $5.0 $6,141 - $10,135	2,027 Added 4606.82%	2,071 $7,000
Q3 2018 Nov 15, 2018	BUY	$5.0 - $6.65 $220 - $292	44 New	44 $0
Q2 2018 Aug 14, 2018	SELL	$4.2 - $5.95 $463,709 - $656,921	-110,407 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.3 - $5.15 $282,621 - $441,061	85,643 Added 345.84%	110,407 $552,000
Q4 2017 Feb 15, 2018	BUY	$3.08 - $3.8 $14,168 - $17,480	4,600 Added 22.81%	24,764 $82,000
Q3 2017 Nov 08, 2017	BUY	$2.7 - $3.75 $54,442 - $75,615	20,164	20,164 $76,000

30.6M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $95.3M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.